Search

Hematology Education & Training

The European Hematology Association (EHA) is the largest provider of independent, evidence-based, and peer-reviewed medical and scientific education in hematology in Europe.

Publications

For the subgroup Rare hereditary blood cancers:
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.

Highlights of Past EHA (HOPE) Latin America (LA) 2023 - report

Nov 28 2023 Posted in Meeting reports

October 26, 2023 – São Paulo, Brazil

Meeting chairs:

A Almeida - President EHA

JF Comenalli Marques Jr - President ABHH

C Chiattone - President HEMO 2023

This year, the HOPE LA meeting was held in collaboration with the Associação Brasileira de Hematologia Hemoterapia e…

Highlights from the SWG

The following activities, which were organized by EMN, also constitute contributions to and participation in the work of the EHA SWG on Multiple Myeloma.

Publications

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey. Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN. Leuk Res. 2017 Oct;61:6-9. doi: 10. 1016/j. leukres. 2017. 08. 002.

Chairs and Members

Chairs
Chair ESLHO: Prof Dr J. J. M. van Dongen, USAL, Salamanca, Spain
Chair EuroFlow: Prof Dr J. J. M van Dongen, USAL, Salamanca, Spain
Chair EuroMRD: Prof Dr M.

Publications

Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD. Martínez-Carrasco R, Sánchez-Abarca LI, Nieto-Gómez C, García EM, Sánchez-Guijo F, Argüeso P, Aijón J, Hernández-Galilea E, Velasco A. Ocul Surf. 2019 Jan 7.